Form 8-K - Current report:
SEC Accession No. 0001104659-25-054587
Filing Date
2025-05-30
Accepted
2025-05-30 08:30:23
Documents
12
Period of Report
2025-05-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516580d1_8k.htm   iXBRL 8-K 408236
  Complete submission text file 0001104659-25-054587.txt   600414

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA glyc-20250530.xsd EX-101.SCH 3029
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20250530_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20250530_pre.xml EX-101.PRE 22368
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2516580d1_8k_htm.xml XML 3544
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 251006649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)